(Q42177351)

18 October 2017

title

Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans (English)

1 reference

18 October 2017

0 references

1 reference

1 reference

7

S R Heckbert

1 reference

18 October 2017

T J Walsh

1

1 reference

18 October 2017

M M Shores

2

1 reference

18 October 2017

A E Fox

3

1 reference

18 October 2017

K P Moore

4

1 reference

18 October 2017

C W Forsberg

5

1 reference

18 October 2017

C E Kinsey

6

1 reference

18 October 2017

S Zeliadt

8

1 reference

18 October 2017

M L Thompson

9

1 reference

18 October 2017

N L Smith

10

1 reference

18 October 2017

A M Matsumoto

11

1 reference

18 October 2017

publication date

13 February 2015

1 reference

18 October 2017

1 reference

18 October 2017

volume

3

1 reference

18 October 2017

issue

2

1 reference

18 October 2017

page(s)

287-292

1 reference

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Prevalence of symptomatic androgen deficiency in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Trends in androgen prescribing in the United States, 2001 to 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Population-based patterns of prescription androgen use, 1976-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Low serum testosterone and increased mortality in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Increased incidence of diagnosed depressive illness in hypogonadal older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Low serum testosterone and mortality in male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Testosterone treatment and mortality in men with low testosterone levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12014

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25684636

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25684636

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/ANDR.12014

1 reference

18 October 2017

0 references

1 reference